✦ LIBER ✦

Phase II trial of denileukin diftitox for relapsed/refractory T-cell non-Hodgkin lymphoma

✍ Scribed by Nam H. Dang; Barbara Pro; Fredrick B. Hagemeister; Felipe Samaniego; Dan Jones; Barry I. Samuels; Maria A. Rodriguez; Andre Goy; Jorge E. Romaguera; Peter McLaughlin; Ann T. Tong; Francesco Turturro; Pamela L. Walker; Luis Fayad

Book ID: 108674108
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 507 KB
Volume: 136
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2006.06457.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of the combination of den

Phase II trial of the combination of denileukin diftitox and rituximab for relapsed/refractory B-cell non-Hodgkin lymphoma

✍ Nam H. Dang; Luis Fayad; Peter McLaughlin; Jorge E. Romaguara; Fredrick Hagemeis 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 447 KB

Multicenter phase II study of bendamusti

Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma

✍ Ken Ohmachi; Kiyoshi Ando; Michinori Ogura; Toshiki Uchida; Kuniaki Itoh; Nobuko 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB

Phase II trial of zanolimumab (HuMax-CD4

Phase II trial of zanolimumab (HuMax-CD4) in relapsed or refractory non-cutaneous peripheral T cell lymphoma

✍ Francesco D’Amore; John Radford; Thomas Relander; Mats Jerkeman; Hervé Tilly; An 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 279 KB

Phase I trial of fludarabine, bortezomib

Phase I trial of fludarabine, bortezomib and rituximab for relapsed and refractory indolent and mantle cell non-Hodgkin lymphoma

✍ Paul M. Barr; Pingfu Fu; Hillard M. Lazarus; Nancy Horvath; Stanton L. Gerson; O 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

Allogeneic haematopoietic stem-cell tran

Allogeneic haematopoietic stem-cell transplantation for relapsed and refractory aggressive histology non-Hodgkin lymphoma

✍ Richard T. Doocey; Cynthia L. Toze; Joseph M. Connors; Thomas J. Nevill; Randy D 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB

A multicenter phase II study of darinapa

A multicenter phase II study of darinaparsin in relapsed or refractory Hodgkin's and non-Hodgkin's lymphoma

✍ Peter J. Hosein; Michael D. Craig; Martin S. Tallman; Ralph V. Boccia; Brian L. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 850 KB

ABVD: doxorubicin,